Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 2
1979 1
1981 3
1982 4
1983 4
1984 5
1985 3
1986 5
1987 5
1988 7
1989 5
1990 2
1991 6
1992 6
1993 9
1994 10
1995 14
1996 10
1997 12
1998 9
1999 7
2000 16
2001 16
2002 17
2003 15
2004 13
2005 12
2006 16
2007 24
2008 19
2009 17
2010 17
2011 15
2012 36
2013 35
2014 25
2015 19
2016 31
2017 19
2018 31
2019 23
2020 27
2021 26
2022 30
2023 26
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

604 results

Results by year

Filters applied: . Clear all
Page 1
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E. André P, et al. Among authors: denis c. Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29. Cell. 2018. PMID: 30503213 Free PMC article. Review.
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.
Whitley J, Zwolinski C, Denis C, Maughan M, Hayles L, Clarke D, Snare M, Liao H, Chiou S, Marmura T, Zoeller H, Hudson B, Peart J, Johnson M, Karlsson A, Wang Y, Nagle C, Harris C, Tonkin D, Fraser S, Capiz L, Zeno CL, Meli Y, Martik D, Ozaki DA, Caparoni A, Dickens JE, Weissman D, Saunders KO, Haynes BF, Sempowski GD, Denny TN, Johnson MR. Whitley J, et al. Among authors: denis c. Transl Res. 2022 Apr;242:38-55. doi: 10.1016/j.trsl.2021.11.009. Epub 2021 Dec 4. Transl Res. 2022. PMID: 34871810 Free PMC article. Review.
[Apalutamide, Erleada®].
Sautois B, Denis C. Sautois B, et al. Among authors: denis c. Rev Med Liege. 2022 Oct;77(10):609-615. Rev Med Liege. 2022. PMID: 36226398 Free article. French.
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease.
Amaya-Garrido A, Brunet M, Buffin-Meyer B, Piedrafita A, Grzesiak L, Agbegbo E, Del Bello A, Ferrandiz I, Ardeleanu S, Bermudez-Lopez M, Fedou C, Camus M, Burlet-Schiltz O, Massines J, Buléon M, Feuillet G, Alves M, Neau E, Casemayou A, Breuil B, Saulnier-Blache JS, Denis C, Voelkl J, Glorieux G, Hobson S, Arefin S, Rahman A, Kublickiene K, Stenvinkel P, Bascands JL, Faguer S, Valdivielso JM, Schanstra JP, Klein J. Amaya-Garrido A, et al. Among authors: denis c. Sci Transl Med. 2023 Sep 6;15(712):eabn5939. doi: 10.1126/scitranslmed.abn5939. Epub 2023 Sep 6. Sci Transl Med. 2023. PMID: 37672568
Hot-Spots of Mcl-1 Protein.
Denis C, Sopková-de Oliveira Santos J, Bureau R, Voisin-Chiret AS. Denis C, et al. J Med Chem. 2020 Feb 13;63(3):928-943. doi: 10.1021/acs.jmedchem.9b00983. Epub 2019 Oct 16. J Med Chem. 2020. PMID: 31580668 Review.
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M, Zawadzki C, Trossaert M, Itzhar-Baïkian N, Dreyfus M, d'Oiron R, Borel-Derlon A, Susen S, Bezieau S, Denis CV, Goudemand J; French Reference Center for von Willebrand disease. Veyradier A, et al. Among authors: denis cv. Medicine (Baltimore). 2016 Mar;95(11):e3038. doi: 10.1097/MD.0000000000003038. Medicine (Baltimore). 2016. PMID: 26986123 Free PMC article.
von Willebrand factor and inflammation.
Kawecki C, Lenting PJ, Denis CV. Kawecki C, et al. Among authors: denis cv. J Thromb Haemost. 2017 Jul;15(7):1285-1294. doi: 10.1111/jth.13696. J Thromb Haemost. 2017. PMID: 28671350 Free article. Review.
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Bou-Jaoudeh M, Mimoun A, Delignat S, Peyron I, Capdevila L, Daventure V, Deligne C, Dimitrov JD, Christophe OD, Denis CV, Lenting PJ, Proulle V, Lacroix-Desmazes S. Bou-Jaoudeh M, et al. Among authors: denis cv. J Thromb Haemost. 2023 Oct;21(10):2776-2783. doi: 10.1016/j.jtha.2023.06.038. Epub 2023 Jul 18. J Thromb Haemost. 2023. PMID: 37473843 Free article.
[Deficiency colitis].
Nelly G, Lewis G, Amar S, Guillaume T, Denis C. Nelly G, et al. Among authors: denis c. Ann Pathol. 2018 Aug;38(4):253-256. doi: 10.1016/j.annpat.2018.03.005. Epub 2018 Apr 19. Ann Pathol. 2018. PMID: 29680293 Review. French. No abstract available.
VWF clearance: it's glycomplicated.
Denis CV, Lenting PJ. Denis CV, et al. Blood. 2018 Feb 22;131(8):842-843. doi: 10.1182/blood-2018-01-824904. Blood. 2018. PMID: 29472372 Free article. No abstract available.
604 results